# Therapeutic Efficacy Study of AL and DP in Western Kenya

> **NCT05060198** · NA · COMPLETED · sponsor: **Kenya Medical Research Institute** · enrollment: 340 (actual)

## Conditions studied

- Malaria,Falciparum

## Interventions

- **DRUG:** Artemether-lumefantrine (AL)
- **DRUG:** Dihydroartemisinin-piperaquine (DP)

## Key facts

- **NCT ID:** NCT05060198
- **Lead sponsor:** Kenya Medical Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-17
- **Primary completion:** 2017-03-13
- **Final completion:** 2020-12-31
- **Target enrollment:** 340 (ACTUAL)
- **Last updated:** 2021-09-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05060198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05060198, "Therapeutic Efficacy Study of AL and DP in Western Kenya". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05060198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*